CVS Health (CVS) February weekly call implied volatility elevated into less than expected guidance

Go back to CVS Health (CVS) February weekly call implied volatility elevated into less than expected guidance

CVS Health (CVS) PT Lowered to $68 at Baird

February 21, 2019 8:35 AM EST

Baird analyst Eric Coldwell lowered the price target on CVS Health (NYSE: CVS) to $68.00 (from $86.00) while maintaining a Neutral rating. Mid-$7 EPS in 2020 looks like a best-case scenario. Derivative reads scattered throughout CVS update, most of them unfavorable for peers/vendors.

CVS is... More